查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
至 2030 年 ELISA 测试市场预测：按类型、技术、应用、最终用户和地区分類的全球分析
市场调查报告书
商品编码
1383390

至 2030 年 ELISA 测试市场预测：按类型、技术、应用、最终用户和地区分類的全球分析

Elisa Tests Market Forecasts to 2030 - Global Analysis By Type (Indirect ELISA, Sandwich ELISA, Competitive ELISA and Multiple and Portable ELISA), Technology (Chemiluminescent, Colorimetric and Fluorescent), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球 ELISA 检测市场规模为 25.5 亿美元，预计在预测期内将以 8.9% 的年复合成长率增长，并在 2030 年达到 46.4 亿美元。

酵素结合免疫吸附测定法是一种标准测定技术，用于识别和定量血液中的抗体、荷尔蒙、胜肽和蛋白质。 ELISA 测试常用于药物品管测试，例如内毒素测定和蛋白质定量，对于许多病毒性疾病的诊断至关重要。 ELISA是植物病理学和医学中的诊断技术，也是许多不同领域的品管测试。酵素结合免疫吸附检测法(ELISA) 测试经常在医学和植物病理学等各个领域用作品质保证测试和筛选仪器。

根据世界卫生组织 (WHO) 统计，2020 年约有 3,770 万人感染爱滋病毒。

对早期准确诊断的需求不断增长

有效的疾病管理和治疗依赖早期和准确的诊断。 ELISA 测试的高灵敏度和特异性使医疗保健专业人员能够识别和检测患者样本中的特定生物标记。早期诊断可以立即开始治疗并显着改善患者的治疗效果。此外，对这些生物标誌物的快速识别使医护人员能够进行干预并快速实施有效的治疗技术。由于对早期准确诊断的需求，ELISA 检测市场正在扩大。

严格的政府法规

诊断药物的行销很困难，因为有些产品被归类为医疗设备，儘管它们的目的是供医生用于诊断。如果没有成功的临床试验，这类设备就无法推出，这是一个耗时、昂贵且不确定的过程。不同国家对这些设备的认证有不同的规则，这对国际公司来说是一个重大挑战。此外，如果各种法规机构（例如 FDA）在产品开发过程中改变法规，则可能会出现潜在的产品推出延迟。这些严格的政府法规是市场成长的主要障碍。

技术开发

ELISA 测试市场受益于技术发展，例如自动化系统的创建、多重功能以及检测灵敏度和特异性的改进。技术进步创造了自动化 ELISA 系统，消除了体力劳动并提高了效率。自动化平台可以同时处理多个样品，从而简化测试程序并提高吞吐量。此外，透过减少週转时间并提高实验室效率，该技术使医护人员能够有效地进行大量测试。由于这些新兴市场的开拓提高了功效、准确性和生产力，从而推动了市场需求，ELISA 测试在许多医疗保健环境中已广泛应用。

竞争替代技术

即时检测 (POCT) 设备、次世代定序(NGS) 和分子诊断技术（例如 PCR）等替代诊断技术与市场上的 ELISA 检测竞争。这些创新具有快速週转时间、更高的灵敏度以及同时检测多种分析物的能力等优点。随着这些技术的发展和变得更加广泛应用，它们可能会取代 ELISA 测试或与 ELISA 测试竞争，特别是在分子诊断具有明显优势的领域。 ELISA 检测市场可能会受到这些替代技术的可用性和普及的威胁。

COVID-19 的影响

最初，在 COVID-19 爆发期间，没有特定的诊断测试来识别患者的疾病。最初尝试了替代诊断方法，但成效有限。此外，某些 COVID-19 诊断测试的无法提供为诊断试剂盒製造商提供了销售 COVID-19 诊断产品的有利可图的机会。利用这个机会，许多老字型大小企业以及来自各国的新兴企业不仅向当地市场而且还向全球市场提供了COVID-19诊断试剂盒。

三明治 ELISA 部分预计将在预测期内成为最大的部分

夹心 ELISA 部分估计占据最大份额。使用由两层抗体（捕获抗体和检测抗体）组成的夹心 ELISA检测抗原。标靶抗原上的两个抗原位点已准备好与抗体结合。在夹心ELISA方法中，使用单株或多株抗体来捕捉和辨识抗体。夹心 ELISA 最适合检测免疫反应，这一事实正在推动市场的扩张。夹心ELISA利用多种抗体来辨识和检测相同抗原，也是最灵敏的检测方法。它也非常弹性和具体。

预计感染疾病领域在预测期内年复合成长率最高

预计感染疾病领域在预测期内将出现良好成长。由于慢性病和传染病的盛行率不断增加，感染疾病目前主导着ELISA市场的应用领域。酵素结合免疫吸附和观察ELISA 测试占主导地位，因为它们是自动化的、易于执行，并且不需要放射性材料或昂贵的辐射设备。

比最大的地区

由于其高度发达的医疗保健系统和不断增长的医疗设备可用性，北美在预测期内占据了最大的市场占有率。製药公司和政府机构针对糖尿病和慢性病等疾病的研发支出的增加也有助于预测期内该地区 ELISA 检测市场的成长。

复合年复合成长率最高的地区：

由于新兴经济体可支配所得和医疗保健支出的增加，预计欧洲在预测期内将出现盈利成长。由于已开发国家医疗设备的使用不断增加，ELISA 检测市场预计在未来年度将成长。此外，由于老年人口众多以及研发投入庞大，预计在预测期内欧洲大陆非传染性疾病的发生率也会增加，从而增加对 ELISA 检测的需求。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球 ELISA 检测市场：按类型

  • 间接ELISA
  • 夹心ELISA
  • 竞争ELISA
  • 多种便携式 ELISA

第6章全球 ELISA 检测市场：依技术分类

  • 化学冷光
  • 比色分析
  • 萤光

第7章全球 ELISA 检测市场：依应用分类

  • 感染疾病
  • 蛋白质定量
  • 疫苗开发
  • 癌症
  • 免疫学
  • 其他用途

第8章全球 ELISA 测试市场：依最终用户分类

  • 製药和生物技术公司
  • 学术研究中心
  • 临床实验室
  • 医院和诊断中心
  • 其他最终用户

第9章全球 ELISA 检测市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Abbott Laboratories
  • Danaher Corporation
  • BioMerieux SA
  • Quidel Corporation
  • Siemens Healthineers
  • Sysmex Corporation
  • Bio-Rad Laboratories
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific, Inc.
  • ZEUS Scientific, Inc.
  • Hoffmann-La Roche AG
  • PerkinElmer, Inc.
  • Enzo Life Sciences, Inc.
  • Agilent Technologies, Inc.
  • R&D Systems, Inc.
  • Bruker
  • Eurofins Scientific
  • ELISA Technologies, Inc
  • BioLegend, Inc
Product Code: SMRC24240

According to Stratistics MRC, the Global Elisa Tests Market is accounted for $2.55 billion in 2023 and is expected to reach $4.64 billion by 2030 growing at a CAGR of 8.9% during the forecast period. The enzyme-linked immune sorbent assay is the standard assay technique used to identify and quantify antibodies, hormones, peptides, and proteins in the blood. The ELISA test is often used in pharmaceutical quality control tests like endotoxin assays and protein quantification and is crucial in the diagnosis of a number of viral diseases. ELISA is a diagnostic technique in plant pathology and medicine as well as a quality control checks in many different sectors. Enzyme-linked immune sorbent assay (ELISA) testing is frequently used as a quality assurance check and screening instrument in a variety of fields, including medicine and plant pathology.

According to the World Health Organization (WHO), around 37.7 million people had HIV in 2020.

Market Dynamics:

Driver:

Rising demand for early and accurate diagnosis

Effective illness management and therapy rely on early and precise diagnosis. The high sensitivity and specificity of Elisa testing enable medical personnel to identify and measure particular biomarkers in patient samples. Early diagnosis enables quick treatment beginning, which can greatly enhance patient results. Additionally, healthcare practitioners can intervene and swiftly implement effective treatment techniques by quickly recognizing these biomarkers. The market for Elisa testing is expanding due to the demand for early and accurate diagnosis.

Restraint:

Stringent government regulations

The marketing of diagnostic products is difficult because some products are categorized as medical devices even though they are intended for use in diagnostic procedures by doctors. Without successfully completing clinical trials, which are a time-consuming, expensive, and uncertain process, such devices cannot be launched. The reality that different countries have different rules for these devices' certification is a significant challenge for international corporations. Additionally, any modifications to rules made by various regulatory agencies, like the FDA, during the product development process may cause a delay in the introduction of potential products. These stringent government regulations are the major barriers to market growth.

Opportunity:

Technological developments

The market for Elisa testing has benefited from technological developments such as the creation of automated systems, the ability to multiplex and enhanced sensitivity and specificity of assays. Technological improvements have led to the creation of automated Elisa systems, excluding manual labor and enhancing efficiency. Multiple samples can be handled simultaneously by automated platforms, streamlining the testing procedure and boosting throughput. Furthermore, by speeding up turnaround times and increasing laboratory efficiency, this technology enables healthcare practitioners to efficiently perform a higher volume of tests. Elisa tests are becoming more widely used in many healthcare settings as a result of these developments, which improve their effectiveness, accuracy, and productivity, which drives market demand.

Threat:

Alternative technologies' competition

Alternative diagnostic technologies, such as point-of-care testing (POCT) devices, next-generation sequencing (NGS), and molecular diagnostic techniques (e.g., PCR), compete with Elisa tests on the market. These innovations have benefits like quicker turnaround times, greater sensitivity, and the capacity to detect multiple analytes at once. Elisa tests may be replaced or competed with as these technologies develop and become more widely available, especially in areas where molecular diagnostics have clear advantages. The market for Elisa tests may be threatened by the availability and uptake of these substitute technologies.

COVID-19 Impact

Initially, in the COVID-19 epidemic, there were no particular diagnostic tests available to identify the illness in patients. Initially, alternative diagnostic procedures were attempted, but they were not very successful. Additionally, due to the unavailability of certain COVID-19 diagnostic tests, diagnostic kit manufacturers had profitable chances to market their COVID-19 diagnostic products. Utilizing this chance, many established companies as well as a few start-ups from different nations offered COVID-19 diagnostic kits to local as well as global markets.

The sandwich ELISA segment is expected to be the largest during the forecast period

The sandwich ELISA segment is estimated to hold the largest share. Antigen is measured using a sandwich ELISA, which consists of two layers of antibodies (the capture antibody and the detection antibody). Two antigenic sites on the target antigens are ready to bind to the antibodies. In sandwich ELISA techniques, monoclonal or polyclonal antibodies are employed to capture and recognize antibodies. Sandwich ELISA works the best for detecting immunological responses, and this fact is promoting market expansion. Sandwich ELISA, which uses a variety of antibodies to bind to the same antigen for recognition or detection, is also the most sensitive test available. It also has a high degree of flexibility and higher specificity.

The infectious diseases segment is expected to have the highest CAGR during the forecast period

The infectious diseases segment is anticipated to have lucrative growth during the forecast period, due to an increase in the prevalence of chronic illnesses and infectious disorders, infectious diseases are now leading the ELISA market's application sector. HIV, HBV, HCV, HTLV, Diphtheria, Giardiasis, and several other infectious blood-borne illnesses The application sector of the enzyme-linked immune sorbent assay (ELISA) testing market is dominated by ELISA tests because they provide quick and accurate findings, have high sensitivity, are automated and simple to perform, and do not require radioactive materials or expensive radiation gear.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the highly developed healthcare system and the growing use of medical gadgets. Rising R&D expenditures by pharmaceutical firms and government organizations for disorders and diseases, including diabetes and chronic illnesses, would also contribute to the market growth for ELISA tests in this region during the projected period.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period due to the rising disposable income and healthcare expenditure in emerging nations. The market for ELISA tests is anticipated to grow in the coming years as a result of the rising use of medical equipment in developed nations. Additionally, due to the large geriatric population and significant investment in research and development, in the projected time frame, it is also anticipated that the rising frequency of non-communicable diseases on the European continent will increase demand for ELISA testing.

Key players in the market

Some of the key players in the Elisa Tests Market include: Abbott Laboratories, Danaher Corporation, BioMerieux SA, Quidel Corporation, Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., ZEUS Scientific, Inc., Hoffmann-La Roche AG, PerkinElmer, Inc., Enzo Life Sciences, Inc., Agilent Technologies, Inc., R&D Systems, Inc., Bruker, Eurofins Scientific, ELISA Technologies, Inc and BioLegend, Inc.

Key Developments:

In May 2023, Abbott, a global leader in health care and nutrition, has partnered with Real Madrid, one of the most successful and popular football clubs in the world, to inaugurate the Abbott-Real Madrid Innovation Lab, a space for collaboration and research on the future of sports physiology and nutrition.

In March 2023, Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, announced an update to their strategic collaboration to further the development of manufacturing processes for new cancer treatments.

In November 2020, Siemens Healthineers announced that its SARS-CoV-2 IgG Antibody Test has proven to evaluate neutralizing antibodies and has gained CE Marking. This test is the better version of its previously launched COVID-19 antibody test.

Types Covered:

  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA
  • Multiple and Portable ELISA

Technologies Covered:

  • Chemiluminescent
  • Colorimetric
  • Fluorescent

Applications Covered:

  • Infectious Diseases
  • Protein Quantitation
  • Vaccine Development
  • Cancer
  • Immunology
  • Other Applications

End Users Covered:

  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Clinical Laboratories
  • Hospitals and Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 TechnologyAnalysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Elisa Tests Market, By Type

  • 5.1 Introduction
  • 5.2 Indirect ELISA
  • 5.3 Sandwich ELISA
  • 5.4 Competitive ELISA
  • 5.5 Multiple and Portable ELISA

6 Global Elisa Tests Market, By Technology

  • 6.1 Introduction
  • 6.2 Chemiluminescent
  • 6.3 Colorimetric
  • 6.4 Fluorescent

7 Global Elisa Tests Market, By Application

  • 7.1 Introduction
  • 7.2 Infectious Diseases
  • 7.3 Protein Quantitation
  • 7.4 Vaccine Development
  • 7.5 Cancer
  • 7.6 Immunology
  • 7.7 Other Applications

8 Global Elisa Tests Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical and Biotech Companies
  • 8.3 Academic Research Centers
  • 8.4 Clinical Laboratories
  • 8.5 Hospitals and Diagnostic Centers
  • 8.6 Other End Users

9 Global Elisa Tests Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Danaher Corporation
  • 11.3 BioMerieux SA
  • 11.4 Quidel Corporation
  • 11.5 Siemens Healthineers
  • 11.6 Sysmex Corporation
  • 11.7 Bio-Rad Laboratories
  • 11.8 Ortho Clinical Diagnostics
  • 11.9 Thermo Fisher Scientific, Inc.
  • 11.10 ZEUS Scientific, Inc.
  • 11.11 Hoffmann-La Roche AG
  • 11.12 PerkinElmer, Inc.
  • 11.13 Enzo Life Sciences, Inc.
  • 11.14 Agilent Technologies, Inc.
  • 11.15 R&D Systems, Inc.
  • 11.16 Bruker
  • 11.17 Eurofins Scientific
  • 11.18 ELISA Technologies, Inc
  • 11.19 BioLegend, Inc

List of Tables

  • Table 1 Global Elisa Tests Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 4 Global Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 5 Global Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 6 Global Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 7 Global Elisa Tests Market Outlook, By Technology(2021-2030) ($MN)
  • Table 8 Global Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 9 Global Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 10 Global Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 11 Global Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 13 Global Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 14 Global Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 15 Global Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 16 Global Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 17 Global Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 18 Global Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 20 Global Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 21 Global Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 22 Global Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 23 Global Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 24 North America Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 26 North America Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 27 North America Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 28 North America Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 29 North America Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 30 North America Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 31 North America Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 32 North America Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 33 North America Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 34 North America Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 35 North America Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 36 North America Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 37 North America Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 38 North America Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 39 North America Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 40 North America Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 North America Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 43 North America Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 44 North America Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 45 North America Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 46 North America Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 47 Europe Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 49 Europe Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 50 Europe Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 51 Europe Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 52 Europe Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 53 Europe Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 54 Europe Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 55 Europe Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 56 Europe Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 57 Europe Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 58 Europe Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 59 Europe Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 60 Europe Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 61 Europe Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 62 Europe Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 63 Europe Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 64 Europe Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 65 Europe Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 66 Europe Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 67 Europe Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 68 Europe Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 69 Europe Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 70 Asia Pacific Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 72 Asia Pacific Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 73 Asia Pacific Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 74 Asia Pacific Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 75 Asia Pacific Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 76 Asia Pacific Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 77 Asia Pacific Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 78 Asia Pacific Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 79 Asia Pacific Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 80 Asia Pacific Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 81 Asia Pacific Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 82 Asia Pacific Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 83 Asia Pacific Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 84 Asia Pacific Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 85 Asia Pacific Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 86 Asia Pacific Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 87 Asia Pacific Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 88 Asia Pacific Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 89 Asia Pacific Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 90 Asia Pacific Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 91 Asia Pacific Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 92 Asia Pacific Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 93 South America Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 95 South America Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 96 South America Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 97 South America Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 98 South America Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 99 South America Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 100 South America Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 101 South America Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 102 South America Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 103 South America Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 104 South America Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 105 South America Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 106 South America Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 107 South America Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 108 South America Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 109 South America Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 110 South America Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 111 South America Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 112 South America Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 113 South America Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 114 South America Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 115 South America Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 116 Middle East & Africa Elisa Tests Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa Elisa Tests Market Outlook, By Type (2021-2030) ($MN)
  • Table 118 Middle East & Africa Elisa Tests Market Outlook, By Indirect ELISA (2021-2030) ($MN)
  • Table 119 Middle East & Africa Elisa Tests Market Outlook, By Sandwich ELISA (2021-2030) ($MN)
  • Table 120 Middle East & Africa Elisa Tests Market Outlook, By Competitive ELISA (2021-2030) ($MN)
  • Table 121 Middle East & Africa Elisa Tests Market Outlook, By Multiple and Portable ELISA (2021-2030) ($MN)
  • Table 122 Middle East & Africa Elisa Tests Market Outlook, By Technology (2021-2030) ($MN)
  • Table 123 Middle East & Africa Elisa Tests Market Outlook, By Chemiluminescent (2021-2030) ($MN)
  • Table 124 Middle East & Africa Elisa Tests Market Outlook, By Colorimetric (2021-2030) ($MN)
  • Table 125 Middle East & Africa Elisa Tests Market Outlook, By Fluorescent (2021-2030) ($MN)
  • Table 126 Middle East & Africa Elisa Tests Market Outlook, By Application (2021-2030) ($MN)
  • Table 127 Middle East & Africa Elisa Tests Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 128 Middle East & Africa Elisa Tests Market Outlook, By Protein Quantitation (2021-2030) ($MN)
  • Table 129 Middle East & Africa Elisa Tests Market Outlook, By Vaccine Development (2021-2030) ($MN)
  • Table 130 Middle East & Africa Elisa Tests Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 131 Middle East & Africa Elisa Tests Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 132 Middle East & Africa Elisa Tests Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 133 Middle East & Africa Elisa Tests Market Outlook, By End User (2021-2030) ($MN)
  • Table 134 Middle East & Africa Elisa Tests Market Outlook, By Pharmaceutical and Biotech Companies (2021-2030) ($MN)
  • Table 135 Middle East & Africa Elisa Tests Market Outlook, By Academic Research Centers (2021-2030) ($MN)
  • Table 136 Middle East & Africa Elisa Tests Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
  • Table 137 Middle East & Africa Elisa Tests Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 138 Middle East & Africa Elisa Tests Market Outlook, By Other End Users (2021-2030) ($MN)